Bioinformatics and Population Sciences

Saro Armenian, D.O., M.P.H.
Dr. Armenian, Professor at the Department of Pediatrics and Population Sciences, is the Director of Childhood Cancer Survivorship Clinic. Dr. Armenian’s research focuses on understanding the effect of childhood cancer on cardiovascular disease and on developing strategies for cardiovascular screening of cancer survivors.
 
Kimlin Tam Ashing, Ph.D.
Dr. Ashing, Professor at the Department of Population Sciences, is the Director of Center of Community Alliance for Research and Education.  Her focus is directed at understanding how social disparities impact heath and patient centered outcomes with the goal of developing strategies to improve quality of life and reduce health inequities.
 
Leslie Bernstein, Ph.D.
Dr. Bernstein, Professor at the Division of Biomarkers of Early Detection and Prevention and Department of Population Sciences, received her PhD from UCLA.  Her research utilizes data from the California Teacher Study to examine questions of cancer etiology, prevention and the impact of modifiable risk factors.
 
Andrea Bild, Ph.D.
Dr. Bild, Professor at the Department of Medical Oncology & Therapeutics Research, received her PhD from University of Colorado, Denver. Her research team uses large-scale translational genomic and pharmacological studies to interrogate and treat tumor heterogeneity and evolution to refractory states. 
 
Wing-Chun (John) Chan, M.D.
Dr. Chan, Dr. Norman and Melinda Payson Professor in Hematologic Cancer, received his MD from University of Hong Kong. Dr. Chan's research focuses on using genomics approaches to explore the molecular pathogenesis and classification of lymphoma. He has identified molecular signature to improve diagnosis, outcome prediction & treatment response for lymphoma patients.
 
Shiuan Chen, Ph.D.
Dr. Chen, Chair of the Department of Cancer Biology, received his PhD from University of Hawaii. His team focuses on refining current treatment strategies and available drugs for better application against breast cancer. He also investigates how environmental chemicals and diet modulate the development of hormone-dependent cancers.
 
Betty Ferrell, Ph.D.
Dr. Ferrell, Director and Professor at the Division of Nursing Research and Education and the Department of Population Sciences, received her PhD from Texas Woman’s University.  Dr. Ferrell is interested in examining quality of life, pain management and palliative care for cancer patients.
 
Stacy Gray, M.D.
Dr. Gray, Associate Clinical Professor at the Department of Medical Oncology & Therapeutic Research, received her MD from University of Chicago. Dr. Gray focuses her research on understanding the psychological effects a person might experience after receiving genetic test results.
 
John Kaddis, Ph.D.
Dr. Kaddis, Assistant Professor at the Department of Diabetes and Cancer Discovery Science, received his PhD from USC. He is currently focused on developing data systems and tools to address cutting edge questions relating to type 1 diabetes.
 
Rick Kittles, Ph.D.
Dr. Kittles, Professor at the Department of Population Sciences and Director of Division of Health Equities, received his PhD from George Washington University. His research interest focuses on genetic and environmental factors and their mechanisms in contributing to disease risks and drug resistance. 
 
James Lacey, Ph.D., M.P.H.
Dr. Lacey, Professor at the Department of Computation and Quantitative Medicine, received his PhD from University of Michigan, Ann Arbor. He is the Director of the Division of Cancer Etiology and is currently focused on developing tools to digitize the California Teachers Study database to make access and analysis more efficient.
 
Keane Lai, M.D. 
Dr. Lai, Associate Clinical Professor at the Department of Pathology, received his MD from University of Pittsburgh.  Dr. Lai is interested in defining the role that the Wnt/β-catenin signaling pathway plays in liver cancer and pancreatic cancer. His laboratory is also working toward identifying novel therapeutic targets in this pathway to combat pancreatic cancer.
 
Jeannine McCune, Pharm.D.
Dr. McCune, Professor at the Department of Population Sciences, received her PharmD from University of North Carolina. Her team is currently developing mathematical models to identify anticancer agent plasma exposure effective at treating cancer and modeling drug doses and frequencies to optimize treatment efficacy. 
 
Susan Neuhausen, Ph.D.
Dr. Neuhausen, Professor at the Department of Population Sciences, received her PhD from University of Minnesota. Her team focuses on identifying genetic, lifestyle, and environmental factors that cause breast, ovarian and prostate cancers, and to uncover what factors are important for disease-free survival in those who develop cancer.  
 
Sunita Patel, Ph.D.
Dr. Patel, Associate Clinical Professor in Population Sciences, received her Ph.D from Alliant University. She is identifying biological & environmental factors as either risk or protective factors for neurocognitive and psychosocial sequelae in cancer patients. Her work includes behavioral interventions to improve health disparities among ethnic minority survivors of childhood cancer.
 
Anne Reb, Ph.D., N.P.
Dr. Reb, Assistant Professor of Division of Nursing Research and Education and the Department of Population Sciences, received her PhD from the Catholic University of America.  Her research is directed at developing models of care to address areas of symptom management and cancer survivorship with particular emphasis on mind-body interventions.
 
Russell Rockne, Ph.D.
Dr. Rockne, Assistant Professor at the Department of Computational and Quantitative Medicine, received his PhD from University of Washington. His work is based upon patient-specific mathematical models of cancer growth and response to therapy, with the goal of using mathematical models to quantify and predict disease dynamics and recurrence. 
 
Andrei Rodin, Ph.D.
Dr. Rodin, Associate Professor at the Department of Diabetes Complications and Metabolism, received his PhD from University of Texas Health Science Center, Houston.  He is developing data analysis methodology and software to analyze large-scale data sets with an emphasis in understanding problems in molecular evolution.
 
Mina Sedrak, M.D., M.S.
Dr. Sedrak, Assistant Professor at the Department of Medical Oncology and Therapeutics Research, received his MD from Rush Medical College.  Dr. Sedrak is focused on examining barriers to clinical trial participation for older adults with cancer as a way to improve evidence based cancer therapy for this population. 
 
Victoria Seewaldt, M.D.
Dr. Seewaldt, Professor and Chair of the Department of Population Sciences, received her MD from UC Davis. Her research focuses on identifying signaling networks that promote breast cancer initiation with the goal of integrating novel functional imaging strategies with risk-marker to provide early detection of interval cancers. 
 
Virginia Sun, Ph.D., R.N.
Dr. Sun, Associate Professor at the Department of Population Sciences, received her PhD from UCLA. Her research includes diet modification for bowel dysfunction in rectal cancer survivors and remote perioperative telemonitoring of patient-reported outcomes and patient-generated health data.
 
Nagarajan Vaidehi, Ph.D.
Dr. Vaidehi, Professor and Chair of the Department of Computational and Quantitative Medicine, received her PhD from Indian Institute of Technology. Her laboratory focuses on developing and applying computational methods to study the structure and dynamics of membrane proteins and protein-protein interactions for identifying small molecule inhibitors. 
 
F. Lennie Wong, Ph.D.
Dr. Wong, Associate Professor at the Departments of Population Sciences and Computational and Quantitative Medicine, Division of Biostatistics, received her PhD from UCLA. She uses computer modeling to address the long-term health issues that childhood cancer survivors may face.  
 
Lisa Yee, M.D. 
Dr. Yee, Professor and Vice Chair of Research of the Department of Surgery, received her MD from Yale University.  Her research is focused on breast cancer prevention and symptom intervention, with emphasis on dietary and nutraceutical interventions.